KOWA COMPANY, LTD. (E02819)

Market cap
P/E ratio
Kowa develops and sells prescription and over-the-counter medicines including popular nutritional drinks and cold remedies, while also operating trading, optical equipment, and hospitality businesses across 117 global subsidiaries.
Period EndNet income (Million JPY)YoY (%)
Mar 31, 202318,200-832.39%
Mar 31, 2022-2,485-260.95%
Mar 31, 20211,544-9.18%
Mar 31, 20201,700-155.30%
Mar 31, 2019-3,074+14.11%
Mar 31, 2018-2,694+112.46%
Mar 31, 2017-1,268-260.51%
Mar 31, 2016790-105.19%
Mar 31, 2015-15,217-1186.15%
Mar 31, 20141,401-9.61%
Mar 31, 20131,550-85.79%
Mar 31, 201210,911+160.41%
Mar 31, 20114,190+84.58%
Mar 31, 20102,270
AI Chat